Finance

Lists
4892:TYO
Cyfuse Biomedical KK
622,00 JP¥
+1,63%
(+10,00) 1D
9 հոկ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4892...
Open
609 JP¥
High
625 JP¥
Low
603 JP¥
Mkt. cap
6,28 մլրդ
Avg. vol.
68,40 հզր
Volume
38,40 հզր
52-wk high
764 JP¥
52-wk low
487 JP¥
EPS
-82 JP¥
No. of employees
23
Open
609 JP¥
High
625 JP¥
Low
603 JP¥
Mkt. cap
6,28 մլրդ
Avg. vol.
68,40 հզր
Volume
38,40 հզր
52-wk high
764 JP¥
52-wk low
487 JP¥
EPS
-82 JP¥
No. of employees
23
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
11 րոպե առաջ
Will Reseller Deal Change Five9 (FIVN) Narrative
Seeking Alpha
Seeking Alpha
·
4 ժամ առաջ
S&P 500 Index Concentration - Room At The Top
About Cyfuse Biomedical KK
CEO-
Employees23
Founded11 օգս, 2010 թ.
Headquarters-
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
32,00 մլն
169,00 մլն
28,00 մլն
76,00 մլն
Cost of goods sold
21,00 մլն
81,00 մլն
8,00 մլն
31,00 մլն
Cost of revenue
21,00 մլն
81,00 մլն
8,00 մլն
31,00 մլն
Research and development expenses
-
416,00 մլն
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
230,00 մլն
-203,00 մլն
236,00 մլն
246,00 մլն
Operating expense
230,00 մլն
227,00 մլն
236,00 մլն
246,00 մլն
Total operating expenses
251,00 մլն
308,00 մլն
244,00 մլն
277,00 մլն
Operating income
-219,00 մլն
-139,00 մլն
-216,00 մլն
-201,00 մլն
Other non operating income
-14,00 մլն
20,00 մլն
-3,00 մլն
-5,00 մլն
EBT including unusual items
-235,00 մլն
-125,00 մլն
-224,00 մլն
-209,00 մլն
EBT excluding unusual items
-235,00 մլն
-125,00 մլն
-224,00 մլն
-209,00 մլն
Income tax expense
-
1,00 մլն
-
1,00 մլն
Effective tax rate
-
-0,80%
-
-0,48%
Other operating expenses
-
-
-
-
Net income
-235,00 մլն
-126,00 մլն
-224,00 մլն
-210,00 մլն
Net profit margin
-734,38%
-74,56%
-800,00%
-276,32%
Earnings per share
-
-
-
-
Interest and investment income
2,00 մլն
-
1,00 մլն
2,00 մլն
Interest expense
-4,00 մլն
-6,00 մլն
-6,00 մլն
-5,00 մլն
Net interest expenses
-2,00 մլն
-6,00 մլն
-5,00 մլն
-3,00 մլն
Depreciation and amortization charges
-
14,00 մլն
-
-
EBITDA
-209,50 մլն
-129,75 մլն
-206,75 մլն
-194,50 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps